Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure

Circulation

Volumn 92, Issue 9 SUPPL., 1995, Pages

  James, Karen B ^a   McCarthy, Patrick M ^a   Thomas, James D ^a   Vargo, Rita ^a   Hobbs, Robert E ^a   Sapp, Shelly ^a   Bravo, Emmanuel ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiomyopathy; heart failure; heart assist device; hormones

Indexed keywords

ADRENALIN; ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; MILRINONE; NEUROHORMONE; NORADRENALIN;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE; HORMONE BLOOD LEVEL; HUMAN; IMPLANTATION; MALE; PATIENT SELECTION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

EID: 0028894990     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.92.9.191     Document Type: Article

References (37)

1. Francis GS, Rector TS, Cohn JN. Sequential neurohormonal measurements in patients with congestive heart failure. Am Heart J. 1988;116:1464-1468.
2. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
3. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin M. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation. 1987; 75(suppl IV):IV-80-IV-92.
4. Gaffney TE, Braunwald E. Importance of adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med. 1963;34:320-324.
5. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Circulation. 1993;87(suppl VI):VI-40-VI-48.
6. Francis GS, Goldsmith SR, Levine TB, Olivera MT, Cohn JT. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984;101:370-377.
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector R. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
8. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-1666.
9. Rector TS, Olivari MT, Levine TB, Francis GL, Cohn JN. Predicting survival for an individual with congestive heart failure using plasma norepinephrine concentration. Am Heart J. 1987; 114: 148-152.
10. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82:1730-1736.
11. Kao W, Gheorghiade M, Hall V, Goldstein S. Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1989; 64: 609-613.
12. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989;13:1534-1539.
13. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Mickas J, Liang C, Kubo SH, Rduin-Toretsky E, Yusuf S, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
14. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympatho-inhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation. 1989;80:65-77.
15. Covit AB, Schaer GL, Sealey JE, Laragh JH, Cody RJ. Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med. 1983;75:445-447.
16. Gheorghiade M, Hall V, Lakier JB, Goldstein S. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combination in patients with severe heart failure. J Am Coll Cardiol. 1989;13:134-142.
17. Alicandri C, Fariello R, Boni E, Zaninelli A, Castellano M, Beschi M, Rosei A, Muiesan G. Captopril versus digoxin in mild-moderate chronic heart failure: a crossover study. J Cardiovasc Phamacol. 1987;9(suppl 2):S61-S67.
18. Ribner HS, Plucinski DA, Hsieh A-M, Bresnahan D, Molteni A, Askenzai J, Lesch M. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study. Am J Cardiol. 1985; 56: 896-904.
19. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987; 316: 1429-1435.
20. Kassis E, Amtorp O. Long-term clinical, hemodynamic, angiographic and neurohormonal responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol. 1990;15:347-352.
21. Jaski BE, Branch KR, Adamson R, Peterson KL, Gordon JB, Hoagland PM, Smith SC, Daily PO, Dembitsky WP. Exercise hemodynamics during long-term implantation of a left ventricular assist device (LVAD) in patients awaiting heart transplantation. J Am Coll Cardiol. 1993;22:1574-1580.
22. Frazier OH, Rose EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL, Dasse KA. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1080-1090.
23. Bravo EL, Tarazi RC, Dustan HP. The mechanism of suppressed plasma renin activity during β-adrenergic blockade with propranolol. J Lab Clin Med. 1974;83:119-124.
24. Suzuki H, Ferrario CM, Septh RC, Brosnihan KB, Smeby RR, DeSilva P. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension. 1983;5(suppl I): I-139-I-149.
25. Crofton JT, Share L, Wang BC, Shade RE. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension. 1980;2:424-431.
26. de Champlain J, Farley L, Cousineau D, Van Ameringen M. Circulating catecholamine levels in human and experimental hypertension. Cric Res. 1976;38:109-114.
27. Rouleau JL, de Champlain J, Klein M, Bichet D, Moye L, Packer M, Dagenais GR, Sussex B, Arnold JM, Sestier F, Parker JO, McEwan P, Bernstein V, Cuddy TE, Lamas G, Gottlieb SS, McCans J, Nadeau C, Delage F, Hamm P, Pfeffer MA. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol. 1993;22:390-398.
28. Mann DL, Kent RL, Parson B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992; 85: 790-804.
29. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiac myocyte necrosis induced by angiotensin II. Circ Res. 1991;69:1185-1195.
30. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 1986;73:503-510.
31. Dubois-Rande' JL, Merlet P, Duval-Moulin AM, Adnot S, Sal JP, Chabrier E, Castaigne A, Geschwind H. Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy. Am Heart J. 1993;125:1329.
32. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-613.
33. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17-22.
34. Rodeheffer RJ, Naruse M, Atkinson JB, Naruse K, Burnett JC, Merrill WH, Frist WH, Demura H, Inagami T. Molecular forms of atrial natriuretic factor in normal and failing human myocardium. Circulation. 1993;88:364-371.
35. Spes CH, Angermann CE, Gerzer R, Dominiak P, Weil J, Beyer RW, Kemkes BM, Theisen K. Plasma hormones in patients with chronic heart failure before and early after orthotopic heart transplantation. Z Kardiol. 1991;80:580-584.
36. Quigg R, Sica D, Griffith L, Roberge P, Salyer J, Gehr T, Quint R. Persistent elevation of neurohormones despite correction of systolic heart failure by cardiac transplantation. J Am Coll Cardiol. 1994; 140A. Abstract.
37. Masters RG, Davies RA, Keon WJ, Walley VM, Koshal A, de Bold AJ. Neuroendocrine response to cardiac transplantation. Can J Cardiol. 1993;9:609-617.